Featured News Image Researcher profiles | Apr 2 2026 Wu Tsai Neurosciences Institute Q&A: ‘To see is to believe’ Faculty Scholar Guosong Hong says that light plays a key role in neuroscience and—and that’s why he’s working with a Big Ideas in Neuroscience team to make transparent brains Image Research news | Apr 1 2026 Wu Tsai Neurosciences Institute Newly identified chronic pain circuit offers pathways to new treatments The research showed that chronic pain is controlled by an entirely separate system than acute pain Image Knight Initiative news | Mar 23 2026 Knight Initiative for Brain Resilience New ideas in aging and resilience research launched by Rosenkranz Foundation and... The Rosenkranz Aging and Rejuvenation Seed Grant Program announced eight innovative new research projects with additional support from the Knight Initiative for Brain Resilience Image Wu Tsai Neuro News | Mar 23 2026 Wu Tsai Neurosciences Institute Announcing the 2026 Neurosciences Postdoctoral Scholars Ten innovative postdoctoral scholars will pursue creative approaches to advance neuroscience and brain resilience research News Filter & Sort Sort by ThemeNeuroHealth NeuroDiscovery News TypePodcast episodes Press coverage Research news Sort by Newest to oldest Oldest to newest Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time. Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest. Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?" Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
Image Researcher profiles | Apr 2 2026 Wu Tsai Neurosciences Institute Q&A: ‘To see is to believe’ Faculty Scholar Guosong Hong says that light plays a key role in neuroscience and—and that’s why he’s working with a Big Ideas in Neuroscience team to make transparent brains
Image Research news | Apr 1 2026 Wu Tsai Neurosciences Institute Newly identified chronic pain circuit offers pathways to new treatments The research showed that chronic pain is controlled by an entirely separate system than acute pain
Image Knight Initiative news | Mar 23 2026 Knight Initiative for Brain Resilience New ideas in aging and resilience research launched by Rosenkranz Foundation and... The Rosenkranz Aging and Rejuvenation Seed Grant Program announced eight innovative new research projects with additional support from the Knight Initiative for Brain Resilience
Image Wu Tsai Neuro News | Mar 23 2026 Wu Tsai Neurosciences Institute Announcing the 2026 Neurosciences Postdoctoral Scholars Ten innovative postdoctoral scholars will pursue creative approaches to advance neuroscience and brain resilience research
Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time.
Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest.
Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
